CHSCM
NEUTRALAt a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
AI-powered fundamental assessment
Key Strengths
Key Risks
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Rule-based valuation (P/E + Graham).
- Insufficient data for clear positives.
Rule-based growth outlook.
- Insufficient data for clear positives.
- Revenue is contracting.
Historical performance + price trend: Shares moved +22.4% over 5Y and +7.9% over 1Y.
- Insufficient data for clear positives.
- Thin profit margins.
Balance sheet & liquidity (Z-Score: N/A).
- Low D/E ratio (0.33).
Dividend policy fallback.
- Moderate dividend profile (Score: 40/100).
- Yield: 6.9%.
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for CHSCM and closest competitors.
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
CHSCM
CHS Inc.
Primary
|
+22.4% | +20.6% | +7.9% | +1.6% | -0.4% | +1.7% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability
Profit margins and return metrics
Growth
Revenue and earnings growth rates
Financial Health
Balance sheet strength and liquidity metrics
Consumer Defensive Sector Comparison
Past News Coverage
Recent headlines mentioning CHSCM from our newsroom.